Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

Chester A. Mathis, Yanming Wang, Daniel Holt, Guo Feng Huang, Manik L. Debnath, William E. Klunk

Research output: Contribution to journalArticle

Abstract

The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [11C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-11C]2-(4′-methylaminophenyl)-6- hydroxybenzothiazole (or [11C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [11C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-3H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Aβ(1-40) fibrils were similar (Kd = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Aβ peptide binding stoichiometry was ∼400-fold higher for AD brain than Aβ(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [11C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Aβ deposition.

Original languageEnglish (US)
Pages (from-to)2740-2754
Number of pages15
JournalJournal of Medicinal Chemistry
Volume46
Issue number13
DOIs
StatePublished - Jun 19 2003
Externally publishedYes

Fingerprint

Amyloid
Brain
Imaging techniques
Papio
Frontal Lobe
Tissue
Lead compounds
Derivatives
Amyloid Plaques
Radioactivity
Metabolites
Stoichiometry
hydroxide ion
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Staining and Labeling
Ligands
Peptides
Injections

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. / Mathis, Chester A.; Wang, Yanming; Holt, Daniel; Huang, Guo Feng; Debnath, Manik L.; Klunk, William E.

In: Journal of Medicinal Chemistry, Vol. 46, No. 13, 19.06.2003, p. 2740-2754.

Research output: Contribution to journalArticle

Mathis, Chester A. ; Wang, Yanming ; Holt, Daniel ; Huang, Guo Feng ; Debnath, Manik L. ; Klunk, William E. / Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. In: Journal of Medicinal Chemistry. 2003 ; Vol. 46, No. 13. pp. 2740-2754.
@article{e1f8e8c6bff6478592950fcfafdefd24,
title = "Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents",
abstract = "The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [11C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-11C]2-(4′-methylaminophenyl)-6- hydroxybenzothiazole (or [11C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [11C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-3H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Aβ(1-40) fibrils were similar (Kd = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Aβ peptide binding stoichiometry was ∼400-fold higher for AD brain than Aβ(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [11C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Aβ deposition.",
author = "Mathis, {Chester A.} and Yanming Wang and Daniel Holt and Huang, {Guo Feng} and Debnath, {Manik L.} and Klunk, {William E.}",
year = "2003",
month = "6",
day = "19",
doi = "10.1021/jm030026b",
language = "English (US)",
volume = "46",
pages = "2740--2754",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

AU - Mathis, Chester A.

AU - Wang, Yanming

AU - Holt, Daniel

AU - Huang, Guo Feng

AU - Debnath, Manik L.

AU - Klunk, William E.

PY - 2003/6/19

Y1 - 2003/6/19

N2 - The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [11C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-11C]2-(4′-methylaminophenyl)-6- hydroxybenzothiazole (or [11C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [11C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-3H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Aβ(1-40) fibrils were similar (Kd = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Aβ peptide binding stoichiometry was ∼400-fold higher for AD brain than Aβ(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [11C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Aβ deposition.

AB - The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [11C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-11C]2-(4′-methylaminophenyl)-6- hydroxybenzothiazole (or [11C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [11C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-3H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Aβ(1-40) fibrils were similar (Kd = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Aβ peptide binding stoichiometry was ∼400-fold higher for AD brain than Aβ(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [11C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Aβ deposition.

UR - http://www.scopus.com/inward/record.url?scp=0038792263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038792263&partnerID=8YFLogxK

U2 - 10.1021/jm030026b

DO - 10.1021/jm030026b

M3 - Article

C2 - 12801237

AN - SCOPUS:0038792263

VL - 46

SP - 2740

EP - 2754

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -